266 related articles for article (PubMed ID: 27481036)
1. Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection.
Khanna S; Montassier E; Schmidt B; Patel R; Knights D; Pardi DS; Kashyap P
Aliment Pharmacol Ther; 2016 Oct; 44(7):715-727. PubMed ID: 27481036
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
3. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.
Allegretti JR; Kearney S; Li N; Bogart E; Bullock K; Gerber GK; Bry L; Clish CB; Alm E; Korzenik JR
Aliment Pharmacol Ther; 2016 Jun; 43(11):1142-53. PubMed ID: 27086647
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection.
Seekatz AM; Rao K; Santhosh K; Young VB
Genome Med; 2016 Apr; 8(1):47. PubMed ID: 27121861
[TBL] [Abstract][Full Text] [Related]
6. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
7. Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
Lee AA; Rao K; Limsrivilai J; Gillilland M; Malamet B; Briggs E; Young VB; Higgins PDR
Inflamm Bowel Dis; 2020 Oct; 26(11):1748-1758. PubMed ID: 31971239
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
Chen Y; Rashid MU; Huang H; Fang H; Nord CE; Wang M; Weintraub A
J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688
[TBL] [Abstract][Full Text] [Related]
9. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
Thabit AK; Housman ST; Burnham CD; Nicolau DP
J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
[TBL] [Abstract][Full Text] [Related]
10. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load.
Han SH; Yi J; Kim JH; Lee S; Moon HW
PLoS One; 2019; 14(2):e0212626. PubMed ID: 30785932
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
[TBL] [Abstract][Full Text] [Related]
12. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
13. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the gut microbiome of patients with
Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
[TBL] [Abstract][Full Text] [Related]
15. The role of gut microbiota in Clostridium difficile infection.
Samarkos M; Mastrogianni E; Kampouropoulou O
Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
[TBL] [Abstract][Full Text] [Related]
16. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Lee YJ; Arguello ES; Jenq RR; Littmann E; Kim GJ; Miller LC; Ling L; Figueroa C; Robilotti E; Perales MA; Barker JN; Giralt S; van den Brink MRM; Pamer EG; Taur Y
J Infect Dis; 2017 Apr; 215(7):1117-1123. PubMed ID: 28498996
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
Naito Y; Kashiwagi K; Takagi T; Andoh A; Inoue R
Digestion; 2018; 97(2):195-204. PubMed ID: 29316555
[TBL] [Abstract][Full Text] [Related]
18. Determining the cause of recurrent Clostridium difficile infection using whole genome sequencing.
Sim JH; Truong C; Minot SS; Greenfield N; Budvytiene I; Lohith A; Anikst V; Pourmand N; Banaei N
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):11-16. PubMed ID: 27771207
[TBL] [Abstract][Full Text] [Related]
19. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
20. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.
Khanna S; Pardi DS; Kelly CR; Kraft CS; Dhere T; Henn MR; Lombardo MJ; Vulic M; Ohsumi T; Winkler J; Pindar C; McGovern BH; Pomerantz RJ; Aunins JG; Cook DN; Hohmann EL
J Infect Dis; 2016 Jul; 214(2):173-81. PubMed ID: 26908752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
